LOGIN
Assessing efficacy of IA injection of LWM fraction of 5% human serum albumin in treatment of knee OA
July 2019
Assessing efficacy of IA injection of LWM fraction of 5% human serum albumin in treatment of knee OA
Study Type:Therapy
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Preliminary Trial of Intra-articular LMWF-5A for Osteoarthritis of the Knee
Orthopedics. 2017 Jan 1;40(1):e49-e53. doi: 10.3928/01477447-20160926-02Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
40 patients with knee osteoarthritis were randomized to three bi-weekly injections of either the low molecular weight fraction of 5% human serum albumin (LMWF-5A) or placebo. Patients were assessed for outcome related to the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and incidence of adverse events. Reduction in WOMAC pain scores from 2 weeks to 12 weeks did not demonst...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.